STOCK TITAN

CDT Equity (CDT) group reports 9.9% ownership; Ascent holds 204,031 shares

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
SCHEDULE 13G

Rhea-AI Filing Summary

CDT Equity Inc. Schedule 13G discloses that a group of related reporting persons collectively report 9.9% beneficial ownership of Common Stock as of 02/17/2026.

The filing shows 255,657 shares as the number with shared voting and dispositive power, Ascent directly holds 204,031 shares, and the ownership percentages are calculated using 2,303,490 shares outstanding and up to 51,626 shares issuable under a Directed Stock Purchase Agreement subject to a 9.99% ownership blocker.

Positive

  • None.

Negative

  • None.

Insights

Group reports a coordinated 9.9% stake with shared control across related entities.

The filing lists correlated entities—Ascent, AP, Dominion affiliates, Masada, and three individuals—reporting shared voting and dispositive power over 255,657 shares and direct Ascent holdings of 204,031 shares as of 02/17/2026.

Ownership percentages are calculated using 2,303,490 shares outstanding and reflect up to 51,626 additional shares issuable under the Directed Stock Purchase Agreement, subject to a stated 9.99% Blocker; subsequent filings may clarify allocation and any transfers.






Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)






SCHEDULE 13G




Comment for Type of Reporting Person: The percentage set forth on row (11) above and the number of shares of common stock, par value 0.0001 per share of the issuer (the "Common Stock") set forth on rows (6), (8) and (9) above includes, up to the Blocker (as defined in this footnote) amount, the purchase of Common Stock by the reporting person pursuant to that certain Directed Stock Purchase Agreement, dated as of January 16, 2026, between the issuer and the reporting person (the "ELOC Agreement") held directly by the reporting person. The ELOC Agreement is subject to a provision contained therein limiting beneficial ownership to an aggregate maximum of 9.99% (the "Blocker"). In Row (11) the percentage is based on (i) 2,303,490 shares of Common Stock outstanding, as reported by the issuer in its Registration Statement on Form S-3 filed with the U.S. Securities and Exchange Commission on January 29, 2026 (the "Form S-3"), and (ii) 18,518,518 shares of Common Stock issuable by the issuer, up to the Blocker amount, pursuant to the ELOC Agreement, each to be directly held by the reporting person.


SCHEDULE 13G




Comment for Type of Reporting Person: The percentage set forth on row (11) above and the number of shares of Common Stock set forth on rows (6), (8) and (9) above includes, up to the Blocker amount, the purchase of Common Stock pursuant to the ELOC agreement to be held indirectly by the reporting person. The ELOC Agreement is subject to the Blocker. In Row (11) the percentage is based on (i) 2,303,490 shares of Common Stock outstanding, as reported by the issuer in the Form S-3, and (ii) 18,518,518 shares of Common Stock issuable by the issuer, up to the Blocker amount, pursuant to the ELOC Agreement, and to be indirectly held by the reporting person.


SCHEDULE 13G




Comment for Type of Reporting Person: The percentage set forth on row (11) above and the number of shares of Common Stock set forth on rows (6), (8) and (9) above includes, up to the Blocker amount, the purchase of Common Stock pursuant to the ELOC agreement to be held indirectly by the reporting person. The ELOC Agreement is subject to the Blocker. In Row (11) the percentage is based on (i) 2,303,490 shares of Common Stock outstanding, as reported by the issuer in the Form S-3, and (ii) 18,518,518 shares of Common Stock issuable by the issuer, up to the Blocker amount, pursuant to the ELOC Agreement, and to be indirectly held by the reporting person.


SCHEDULE 13G




Comment for Type of Reporting Person: The percentage set forth on row (11) above and the number of shares of Common Stock set forth on rows (6), (8) and (9) above includes, up to the Blocker amount, the purchase of Common Stock pursuant to the ELOC agreement to be held indirectly by the reporting person. The ELOC Agreement is subject to the Blocker. In Row (11) the percentage is based on (i) 2,303,490 shares of Common Stock outstanding, as reported by the issuer in the Form S-3, and (ii) 18,518,518 shares of Common Stock issuable by the issuer, up to the Blocker amount, pursuant to the ELOC Agreement, and to be indirectly held by the reporting person.


SCHEDULE 13G




Comment for Type of Reporting Person: The percentage set forth on row (11) above and the number of shares of Common Stock set forth on rows (6), (8) and (9) above includes, up to the Blocker amount, the purchase of Common Stock pursuant to the ELOC agreement to be held indirectly by the reporting person. The ELOC Agreement is subject to the Blocker. In Row (11) the percentage is based on (i) 2,303,490 shares of Common Stock outstanding, as reported by the issuer in the Form S-3, and (ii) 18,518,518 shares of Common Stock issuable by the issuer, up to the Blocker amount, pursuant to the ELOC Agreement, and to be indirectly held by the reporting person.


SCHEDULE 13G




Comment for Type of Reporting Person: The percentage set forth on row (11) above and the number of shares of Common Stock set forth on rows (6), (8) and (9) above includes, up to the Blocker amount, the purchase of Common Stock pursuant to the ELOC agreement to be held indirectly by the reporting person. The ELOC Agreement is subject to the Blocker. In Row (11) the percentage is based on (i) 2,303,490 shares of Common Stock outstanding, as reported by the issuer in the Form S-3, and (ii) 18,518,518 shares of Common Stock issuable by the issuer, up to the Blocker amount, pursuant to the ELOC Agreement, and to be indirectly held by the reporting person.


SCHEDULE 13G




Comment for Type of Reporting Person: The percentage set forth on row (11) above and the number of shares of Common Stock set forth on rows (6), (8) and (9) above includes, up to the Blocker amount, the purchase of Common Stock pursuant to the ELOC agreement to be held indirectly by the reporting person. The ELOC Agreement is subject to the Blocker. In Row (11) the percentage is based on (i) 2,303,490 shares of Common Stock outstanding, as reported by the issuer in the Form S-3, and (ii) 18,518,518 shares of Common Stock issuable by the issuer, up to the Blocker amount, pursuant to the ELOC Agreement, and to be indirectly held by the reporting person.


SCHEDULE 13G




Comment for Type of Reporting Person: The percentage set forth on row (11) above and the number of shares of Common Stock set forth on rows (6), (8) and (9) above includes, up to the Blocker amount, the purchase of Common Stock pursuant to the ELOC agreement to be held indirectly by the reporting person. The ELOC Agreement is subject to the Blocker. In Row (11) the percentage is based on (i) 2,303,490 shares of Common Stock outstanding, as reported by the issuer in the Form S-3, and (ii) 18,518,518 shares of Common Stock issuable by the issuer, up to the Blocker amount, pursuant to the ELOC Agreement, and to be indirectly held by the reporting person.


SCHEDULE 13G




Comment for Type of Reporting Person: The percentage set forth on row (11) above and the number of shares of Common Stock set forth on rows (6), (8) and (9) above includes, up to the Blocker amount, the purchase of Common Stock pursuant to the ELOC agreement to be held indirectly by the reporting person. The ELOC Agreement is subject to the Blocker. In Row (11) the percentage is based on (i) 2,303,490 shares of Common Stock outstanding, as reported by the issuer in the Form S-3, and (ii) 18,518,518 shares of Common Stock issuable by the issuer, up to the Blocker amount, pursuant to the ELOC Agreement, and to be indirectly held by the reporting person.


SCHEDULE 13G



Ascent Partners Fund LLC
Signature:/s/ Ascent Partners Fund LLC
Name/Title:Mikhail Gurevich, signatory for Managing Member of Managing Member
Date:02/18/2026
Ascent Partners LLC
Signature:/s/ Ascent Partners LLC
Name/Title:Mikhail Gurevich, signatory for Managing Member
Date:02/18/2026
Dominion Capital LLC
Signature:/s/ Dominion Capital LLC
Name/Title:Mikhail Gurevich, Managing Member of Dominion Capital Holdings LLC, Manager of Dominion Capital GP LLC, Manager of Dominion Capital LLC
Date:02/18/2026
Dominion Capital GP LLC
Signature:/s/ Dominion Capital GP LLC
Name/Title:Mikhail Gurevich, Managing Member of Dominion Capital Holdings LLC
Date:02/18/2026
Dominion Capital Holdings LLC
Signature:/s/ Dominion Capital Holdings LLC
Name/Title:Mikhail Gurevich, Managing Member
Date:02/18/2026
Masada Group Holdings LLC
Signature:/s/ Masada Group Holdings LLC
Name/Title:Alon Brenner, Managing Member
Date:02/18/2026
Mikhail Gurevich
Signature:/s/ Mikhail Gurevich
Name/Title:Mikhail Gurevich
Date:02/18/2026
Gennadiy Gurevich
Signature:/s/ Gennadiy Gurevich
Name/Title:Gennadiy Gurevich
Date:02/18/2026
Alon Brenner
Signature:Alon Brenner
Name/Title:Alon Brenner
Date:02/18/2026

Comments accompanying signature: Exhibit 1 - Joint Filing Agreement

FAQ

What stake does the CDT (CDT) reporting group disclose?

The group reports 9.9% beneficial ownership of Common Stock as of 02/17/2026. This percentage uses 2,303,490 shares outstanding and includes shares issuable subject to a 9.99% ownership blocker.

How many shares does Ascent Partners directly hold in CDT?

Ascent Partners directly holds 204,031 shares of Common Stock as of 02/17/2026. The filing shows additional shares are issuable under a Directed Stock Purchase Agreement, constrained by the 9.99% Blocker.

What is the shared voting and dispositive power reported?

The reporting group discloses shared voting power and shared dispositive power over 255,657 shares. These shared powers reflect coordinated control among the named entities and individuals in the joint filing agreement.

How were the ownership percentages calculated in the filing?

Percentages are calculated using 2,303,490 shares outstanding reported in the Form S-3 and up to 18,518,518 potential issuable shares referenced in the agreement, capped by the 9.99% Blocker resulting in 51,626 shares issuable under the Blocker.

Who are the reporting persons named in the Schedule 13G?

The reporting persons include Ascent Partners Fund LLC, Ascent Partners LLC, Dominion Capital entities, Masada Group Holdings LLC, and individuals Mikhail Gurevich, Gennadiy Gurevich, and Alon Brenner, who signed a Joint Filing Agreement.
CDT Equity

NASDAQ:CDT

CDT Rankings

CDT Latest News

CDT Latest SEC Filings

CDT Stock Data

2.14M
1.82M
Biotechnology
Pharmaceutical Preparations
Link
United States
NAPLES